FDA inspection
AmbioPharm, Inc: FDA inspection ending Jul 5, 2017
FDA inspection 1018621 · Voluntary Action Indicated (VAI) · Beech Island, SC
Key facts
| Inspection ID | 1018621 |
|---|---|
| Firm | AmbioPharm, Inc |
| FEI number | 3006446551 |
| Address | 1024 Dittman Ct |
| City | Beech Island |
| State | SC |
| ZIP | 29842 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jul 5, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data